GRAIL Patents

Patent portfolio assigned to GRAIL (verified via public assignee records). Multi-cancer early detection company (Galleri test; NASDAQ: GRAL, formerly part of Illumina). Customers are PATHFINDER health-system partners + Quest lab collaboration. Holds many patents on methylation/sequencing/cancer-detection (Google Patents + Justia assignee 'GRAIL, LLC'); exact count not captured (Justia page blocked direct fetch).